Studies related to Isaac Speech Activity Test and Vinpocetine

[Efficacy Of Vinpotropile In The Therapy Of Initial Signs Of Cerebrovascular Pathology]

Effect Increase
Trial Design Cohort
Trial Length 1-6 months
Number of Subjects 20
Sex Both Genders
Age Range 45-64, 65+
Body Types Overweight
Notes for this study:
Used vinpotropile (Pyracetam) as oral dose for 30 days in patients aged 50-78 with beginning stages of chronic brain ischemia. The rate of cognitive decline appears to be attenuated as assessed by the MMSE rating scale, and subjective well being increased.